Friday, October 21, 2016
Video: Page (1) of 1 - 04/19/13 Email this story to a friend. email article Print this page (Article printing at page facebook
Analyst Moves: VRTX, NFLX, APH

By DMO Affiliate
This morning, Deutsche Bank increased its price target on shares of Vertex Pharmaceutical (VRTX) to $100 following news that the company's cystic fibrosis treatment is performing better than expected. Shares of VRTX were sharply higher this morning, gaining more than 55% on the news.
Analyst Moves: VRTX, NFLX, APH

Page: 1


Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines